Cantitate/Preț
Produs

Process Chemistry in the Pharmaceutical Industry

Editat de Kumar Gadamasetti
en Limba Engleză Hardback – 6 mai 1999
Providing guidance for chemists and other scientists entering pharmaceutical discovery and development, this up-to-the-minute reference presents contributions from an international group of nearly 50 renowned researchers—offering a solid grounding in synthetic and physical organic chemistry, and clarifying the roles of various specialties in the development of new drugs. Featuring over 1000 references, tables, and illustrations, Process Chemistry in the Pharmaceutical Industry is sure to find its way to the bookshelves of organic, physical, analytical, process, and medicinal chemists and biochemists; pharmacists; and upper-level undergraduate and graduate students in these disciplines.
Citește tot Restrânge

Preț: 194818 lei

Preț vechi: 237582 lei
-18% Nou

Puncte Express: 2922

Preț estimativ în valută:
37277 39026$ 30845£

Carte tipărită la comandă

Livrare economică 05-19 aprilie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780824719814
ISBN-10: 0824719816
Pagini: 500
Dimensiuni: 174 x 246 x 37 mm
Greutate: 1.09 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press

Public țintă

Professional

Cuprins

Overview

Process Chemistry in the Pharmaceutical Industry: An Overview, Kumar G. Gadamasetti

Strategy

Process Research and Development Strategy for Accelerated Projects, Christopher M. Cimarusti

Case Studies

A Practical Synthesis of Ifetroban Sodium, Richard H. Mueller
Synthesis of 5-Lipoxygenase Inhibitors, Ivan Lantos and Richard Matsuoka
Chemistry of Vitamin D: A Challenging Field for Process Research, Masami Okabe
A Highly Optimized and Concise Large Scale Synthesis of a Purine Bronchodilator, Hans-Jürgen Federsel and Edib Jakupovic
Ontazolast: The Evolution of a Process, Vittorio Farina, Karl Grozinger, Hermann Müller-Bötticher and Gregory P. Roth
Dilevalol Hydrochloride: Development of a Commercial Process, Derek Walker
Design and Development of Practical Syntheses of LY228729, a Potent 5HT1a Receptor Agonist, Michael J. Martinelli and David L. Varie
Process Research and Development of CGS 19755, an NMDA Antagonist, Peter Giannousis, John Carlson and Marius Leimer
Route Evaluation for the Production of (R)-Levoprotiline, H. U. Blaser, R. Gamboni, B. Pugin, G. Rihs, G. Sedelmeier, E. Schaub, E. Schmidt, B. Schmitz, F. Spindler and Hj. Wetter
The Process Research and Development of DuPont Merck’s Cyclic Urea Diols, A New Class of HIV Protease Inhibitors, Pat N. Confalone and Robert E. Waltermire
Practical Enantio- and Diastereo-selective Processes for Azetidinones, T. K. Thiruvengadam, Anantha R. Sudhakar, and Guangzhong Wu
Synthesis of the Common Lactone Moiety of HMG-CoA Reductase Inhibitors, Ian M. McFarlane, Christopher G. Newton and Philippe Pitchen

Enzymatic Intervention and Phase Transfer Catalysis

Chemistry, Biocatalysis and Engineering: An Interdisciplinary Approach to the Manufacture of the Benzodiazepine Drug Candidate LY 300164, Benjamin A. Anderson, Marvin M. Hansen, Jeffrey T. Vicenzi and Milton J. Zmijewski
Benefits and Challenges of Applying Phase-Transfer Catalysis Technology in the Pharmaceutical Industry, Marc E. Halpern

Asymmetric Synthesis and Enantioselectivity

Enantioselective Synthesis: The Optimum Process, John J. Partridge and Brian L. Bray
Practical Catalysts for Asymmetric Synthesis: Ligands from Natural Sugars for Rh-Catalyzed Asymmetric Synthesis of D- and L- Amino Acids, Timothy A. Ayers and T. V. Rajan Babu
Chiral (Salen)Mn(III) Complexes in Asymmetric Epoxidations: Practical Synthesis of cis-Aminoindanol and Its Application to Enantiopure Drug Synthesis, Chris H. Senanayake and Eric N. Jacobsen

Drug Substance Final Form and Process Safety

Chemical Development of the Drug Substance Solid Form, Michael D. Thompson and Jean-René Authelin
The Basic Principles of Thermal Process Safety: Towards a Better Communication Between Safety Experts and Process Chemists, Wilfried Hoffmann

Design of Experiments and Automation

Using Factorial Experiments in the Development of Process Chemistry, Daniel R. Pilipauskas
Laboratory Automation in Chemical Development, Martin R. Owen and Sheila H. Dewitt

Recenzii

”...the book successfully achieves its goal of presenting the basic principles and challenges associated with the discovery and scale-up of a commercial manufacturing process of a new drug.”
Journal of Medicinal Chemistry

”...gives a thorough overview of the challenges facing the modern development chemists in the pharmaceutical industry. It can be recommended to any graduates or postgraduates considering a career in this fascinating field, and even old hands will find much stimulating chemistry in the case studies. “
Organic Process Research & Development

”...provides a good overview for those wanting an introduction to the science conducted in a process research group. For experienced process chemists, frequent descriptions of creative solutions to difficult problems makes the book worth reading.”
Journal of the American Chemical Society

”...recommended without reservation. It is suitable not only for the process chemist but also for those involved in preparative work in research in teaching, and for advanced students. It should find a place in every chemical library.”
Angewandte Chemie

”...presents pharmaceutical synthesis at its best in a very concise and educational way. The wealth of references and illustrations, and the carefully compiled subject index guarantees fast access to further information....the lively style in which chapters are written keeps the reader interested along the way.”
European Journal of Pharmaceutics and Biopharmaceutics, 2000

Descriere

An ideal guide for scientists entering pharmaceutical discovery and development, this reference also clarifies the roles of various specialties in of new drug development. Featuring contributions from nearly 50 renowned researchers and over 1000 references, tables, and illustrations, it offers a solid grounding in synthetic as well asphysical organic chemistry. This seminal volume highlights new strategies for aggressive drug development programs, green synthesis processes, and other trends in the industry. It illustrates the impact of non-traditional small molecules as a therapeutic agent, including 12 case studies on agents such as inhibitors and antangonists.